speb/financial-data huggingface dataset:
XYZ.AX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
XYZ.AX balance_sheet (annual, 2025-12-31) — Total Assets: 39549887000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Total Assets: 39549887000.00
XYZ.AX balance_sheet (annual, 2025-12-31) — Total Capitalization: 28817978000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 28817978000.00
XYZ.AX balance_sheet (annual, 2025-12-31) — Total Debt: 8966376000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Total Debt: 8966376000.00
XYZ.AX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 22169882000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 22169882000.00
XYZ.AX income_statement (annual, 2025-12-31) — Total Expenses: 21148031000.00
XYZ.AX income_statement (quarterly, 2025-12-31) — Total Expenses: 5257095000.00
XYZ.AX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 17380005000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 17380005000.00
XYZ.AX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 16693007000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 16693007000.00
XYZ.AX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6995545000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6995545000.00
XYZ.AX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1708406000.00
XYZ.AX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 485371000.00
XYZ.AX income_statement (annual, 2025-12-31) — Total Other Finance Cost: 129363000.00
XYZ.AX income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 53781000.00
XYZ.AX income_statement (annual, 2025-12-31) — Total Unusual Items: -1393146000.00
XYZ.AX income_statement (quarterly, 2025-12-31) — Total Unusual Items: -744314000.00
XYZ.AX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1393146000.00
XYZ.AX income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -744314000.00
XYZ.AX balance_sheet (annual, 2025-12-31) — Working Capital: 12472420000.00
XYZ.AX balance_sheet (quarterly, 2025-12-31) — Working Capital: 12472420000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — +Operating Expense: 2581104000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — +Total Revenue: 6056847000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 134013000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3753516000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 18601896000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -236688000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Amortization: 34159000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 34159000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 745612000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 88112000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 0.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 597586000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.52
XYZ.AX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 12481276000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -30574000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 298371000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 12799537000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 13262148000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 1090189000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 11709348000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -251910000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 300030000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 965595000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -122404000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 557539000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Change In Payable: -122404000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -122404000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -70774000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Change In Receivables: 89666000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 454027000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 89666000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1013715000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 21715338000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -635988000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3147608000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1014995000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Assets: 23766425000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 56026000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Debt: 1857936000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1913962000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 352775000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 352775000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 11967110000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -79027000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Deferred Tax: -79027000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 95977000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 34159000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 95977000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 34159000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 597586000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.52
XYZ.AX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -308681000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — EBIT: -339382000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — EBITDA: -243405000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 5665000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -471000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — End Cash Position: 13494520000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -251910000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 935021000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 172818000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -172818000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -252131000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 857564000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Goodwill: 11956264000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 13202048000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3990204000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 483288000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Gross Profit: 2909239000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 154625000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Interest Expense: 53195000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 53195000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Inventory: 174318000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 29550358000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 300030000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 242737000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 860027000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 223953000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 3430619000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 242345000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 5977084000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 6219429000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 223953000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1065192000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Minority Interest: -34310000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Minority Interests: -86000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -635988000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Income: -308681000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -308681000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -308595000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -308681000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -308681000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -308595000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -308595000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Interest Income: -53195000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -322006000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -841239000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -841239000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -53195000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 1224699000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 652610000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Net PPE: 483288000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -30574000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 8513290000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1380684000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 54000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1380684000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 54000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 429538000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Normalized Income: 189296820.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 965595000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 178483000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Operating Income: 328135000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Operating Revenue: 6056847000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 595271000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 841664000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1857936000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 250798000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -252131000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Other Gand A: 857564000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Other Income Expense: -667517000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1245784000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Investments: 617290000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 286030000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 293609000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 118460000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 5426000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Payable: 7973367000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Properties: 483288000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 577743000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 462611000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Payables: 8107380000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 9122375000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 327200000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 359481000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Pretax Income: -392577000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 618000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -10721006000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -30574000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Receivables: 7761878000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3085790000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 95977000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1065192000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -635988000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Research And Development: 1038873000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 621324000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 500125000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3365573000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 10399000000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 650508000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1508072000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Share Issued: 595271000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Special Income Charges: -500125000.00
XYZ.AX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 338700000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 21715338000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 8513290000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -174965180.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Tax Provision: -83982000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Total Assets: 39986081000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 27692422000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Total Debt: 8133391000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 21681028000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Total Expenses: 5728712000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 18305053000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 16219656000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6337943000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -171990000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Total Unusual Items: -672943000.00
XYZ.AX income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -672943000.00
XYZ.AX balance_sheet (quarterly, 2026-03-31) — Working Capital: 11799315000.00
XZO income_statement (annual, 2022-12-31) — Basic Average Shares: 90775789.00
XZO income_statement (annual, 2022-12-31) — Basic EPS: -0.75
XZO income_statement (annual, 2022-12-31) — Diluted Average Shares: 90775789.00
XZO income_statement (annual, 2022-12-31) — Diluted EPS: -0.75
XZO income_statement (annual, 2023-12-31) — Basic Average Shares: 90775789.00
XZO income_statement (annual, 2023-12-31) — Basic EPS: 0.13
XZO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -3247000.00
XZO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -888000.00
XZO cash_flow (annual, 2023-12-31) — Change In Receivables: -1636000.00
XZO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 0.00
XZO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
XZO balance_sheet (annual, 2023-12-31) — Current Deferred Assets: 3223000.00
XZO income_statement (annual, 2023-12-31) — Diluted Average Shares: 90775789.00
XZO income_statement (annual, 2023-12-31) — Diluted EPS: 0.13
XZO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
XZO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 3223000.00
XZO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -1803000.00
XZO balance_sheet (annual, 2023-12-31) — Receivables: 9129000.00
XZO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 90775789.00
XZO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.06
XZO cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: 0.00
XZO cash_flow (quarterly, 2024-09-30) — Common Stock Payments: -388000.00
XZO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 90775789.00
XZO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.06
XZO income_statement (quarterly, 2024-09-30) — Interest Expense: 15000.00
XZO income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 15000.00
XZO cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
XZO cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
XZO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: -388000.00
XZO income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
XZO income_statement (quarterly, 2024-09-30) — Net Interest Income: -15000.00
XZO cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
XZO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
XZO income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: -15000.00
XZO cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -884000.00
XZO cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
XZO cash_flow (quarterly, 2024-09-30) — Preferred Stock Dividend Paid: 0.00
XZO cash_flow (quarterly, 2024-09-30) — Preferred Stock Payments: 0.00
XZO cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -884000.00
XZO cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: -388000.00
XZO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
XZO balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 0.00
XZO income_statement (annual, 2024-12-31) — Basic Average Shares: 90775789.00
XZO income_statement (annual, 2024-12-31) — Basic EPS: 0.39
XZO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -3334000.00
XZO cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
XZO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 17884000.00
XZO cash_flow (annual, 2024-12-31) — Change In Receivables: -3083000.00
XZO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 0.00
XZO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
XZO cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
XZO balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 6397000.00
XZO balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 6397000.00
XZO income_statement (annual, 2024-12-31) — Diluted Average Shares: 90775789.00
XZO income_statement (annual, 2024-12-31) — Diluted EPS: 0.39
XZO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
XZO balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 0.00
XZO income_statement (quarterly, 2024-12-31) — Interest Expense: 8000.00
XZO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 8000.00
XZO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
XZO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
XZO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
XZO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
XZO income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
XZO income_statement (quarterly, 2024-12-31) — Net Interest Income: -8000.00
XZO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -2994000.00
XZO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -2994000.00
XZO income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -8000.00
XZO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -648000.00
XZO cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
XZO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 3132000.00
XZO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 3132000.00
XZO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
XZO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
XZO income_statement (annual, 2024-12-31) — Normalized Income: 25662583.27
XZO cash_flow (quarterly, 2024-12-31) — Preferred Stock Dividend Paid: 0.00
XZO income_statement (quarterly, 2024-12-31) — Preferred Stock Dividends: 0.00
XZO cash_flow (quarterly, 2024-12-31) — Preferred Stock Payments: 0.00
XZO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -648000.00
XZO balance_sheet (annual, 2024-12-31) — Receivables: 5680000.00
XZO balance_sheet (quarterly, 2024-12-31) — Receivables: 5680000.00
XZO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
XZO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 142583.27
XZO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.26
XZO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
XZO balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
XZO income_statement (quarterly, 2025-03-31) — +Operating Expense: 5028000.00
XZO income_statement (quarterly, 2025-03-31) — +Total Revenue: 52407000.00
XZO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 90701189.00
XZO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.20
XZO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 54502000.00
XZO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -769000.00
XZO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -769000.00
XZO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
XZO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -769000.00
XZO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 19772000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 3980000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 604000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 2000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -118000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -1977000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Payable: 4584000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 4584000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 53000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 185000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 604000.00
XZO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2729000.00
XZO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 0.00
XZO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 19003000.00
XZO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 23582000.00
XZO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -2338000.00
XZO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -2338000.00
XZO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 709000.00
XZO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 101000.00
XZO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 709000.00
XZO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 101000.00
XZO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 90701189.00
XZO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.20
XZO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 17951000.00
XZO income_statement (quarterly, 2025-03-31) — EBIT: 23797000.00
XZO income_statement (quarterly, 2025-03-31) — EBITDA: 24506000.00
XZO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -11000.00
XZO cash_flow (quarterly, 2025-03-31) — End Cash Position: 73494000.00
XZO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
XZO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 19003000.00
XZO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 398000.00
XZO income_statement (quarterly, 2025-03-31) — Gross Profit: 28825000.00
XZO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -769000.00
XZO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -2000.00
XZO income_statement (quarterly, 2025-03-31) — Net Income: 17951000.00
XZO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 17951000.00
XZO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 17951000.00
XZO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 17951000.00
XZO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 17951000.00
XZO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 17951000.00
XZO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 17951000.00
XZO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
XZO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 24108000.00
XZO income_statement (quarterly, 2025-03-31) — Normalized Income: 17655684.00
XZO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 19772000.00
XZO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2000.00
XZO income_statement (quarterly, 2025-03-31) — Operating Income: 23797000.00
XZO income_statement (quarterly, 2025-03-31) — Operating Revenue: 50079000.00
XZO income_statement (quarterly, 2025-03-31) — Other Income Expense: 398000.00
XZO income_statement (quarterly, 2025-03-31) — Pretax Income: 24195000.00
XZO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
XZO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 22974000.00
XZO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 709000.00
XZO income_statement (quarterly, 2025-03-31) — Research And Development: 2221000.00
XZO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2706000.00
XZO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 723000.00
XZO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 102684.00
XZO income_statement (quarterly, 2025-03-31) — Tax Provision: 6244000.00
XZO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
XZO income_statement (quarterly, 2025-03-31) — Total Expenses: 28610000.00
XZO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 23797000.00
XZO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 398000.00
XZO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 398000.00
XZO income_statement (quarterly, 2025-06-30) — +Operating Expense: 5424000.00
XZO income_statement (quarterly, 2025-06-30) — +Total Revenue: 56091000.00
XZO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 73494000.00
XZO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -483000.00
XZO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
XZO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -483000.00
XZO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 37754000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1804000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -1743000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -62000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 12860000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Payable: 1200000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1200000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -113000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 4965000.00
XZO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 17107000.00
XZO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 37271000.00
XZO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 22540000.00
XZO balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 6170000.00
XZO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2502000.00
XZO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2502000.00
XZO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 730000.00
XZO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 110000.00
XZO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 730000.00
XZO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 110000.00
XZO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 21663000.00
XZO income_statement (quarterly, 2025-06-30) — EBIT: 29288000.00
XZO income_statement (quarterly, 2025-06-30) — EBITDA: 30018000.00
XZO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -33000.00
XZO cash_flow (quarterly, 2025-06-30) — End Cash Position: 110732000.00
XZO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
XZO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 37271000.00
XZO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 763000.00
XZO income_statement (quarterly, 2025-06-30) — Gross Profit: 33551000.00
XZO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -483000.00
XZO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 50000.00
XZO income_statement (quarterly, 2025-06-30) — Net Income: 21663000.00
XZO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 21663000.00
XZO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 21663000.00
XZO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 21663000.00
XZO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 21663000.00
XZO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 21663000.00
XZO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 21663000.00
XZO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 4124000.00
XZO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 29255000.00
XZO income_statement (quarterly, 2025-06-30) — Normalized Income: 21090868.85
XZO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 37754000.00
XZO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 50000.00
XZO income_statement (quarterly, 2025-06-30) — Operating Income: 28127000.00
XZO income_statement (quarterly, 2025-06-30) — Operating Revenue: 53918000.00
XZO income_statement (quarterly, 2025-06-30) — Other Income Expense: 763000.00
XZO balance_sheet (quarterly, 2025-06-30) — Other Properties: 18034000.00
XZO income_statement (quarterly, 2025-06-30) — Pretax Income: 28890000.00
XZO balance_sheet (quarterly, 2025-06-30) — Receivables: 19025000.00
XZO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 21920000.00
XZO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 730000.00
XZO income_statement (quarterly, 2025-06-30) — Research And Development: 2354000.00
XZO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2960000.00
XZO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 706000.00
XZO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 190868.85
XZO income_statement (quarterly, 2025-06-30) — Tax Provision: 7227000.00
XZO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
XZO income_statement (quarterly, 2025-06-30) — Total Expenses: 27964000.00
XZO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 28127000.00
XZO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 763000.00
XZO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 763000.00
XZO income_statement (quarterly, 2025-09-30) — +Operating Expense: 6521000.00
XZO income_statement (quarterly, 2025-09-30) — +Total Revenue: 55166000.00
XZO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 15600000.00
XZO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 74915000.00
XZO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 90775789.00
XZO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.23
XZO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 110732000.00
XZO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1189000.00
XZO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 7515000.00
XZO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 83000.00
XZO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 140919000.00
XZO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 140919000.00
XZO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1189000.00
XZO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 31491000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 3362000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -127000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 101000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 10666000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Payable: 3362000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3362000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -455000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -7638000.00
XZO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 5909000.00
XZO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 30302000.00
XZO balance_sheet (quarterly, 2025-09-30) — Common Stock: 83000.00
XZO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 78432000.00
XZO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
XZO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 21393000.00
XZO balance_sheet (quarterly, 2025-09-30) — Current Assets: 162646000.00
XZO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2351000.00
XZO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2351000.00
XZO balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 5379000.00
XZO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 73102000.00
XZO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 73102000.00
XZO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 93926000.00
XZO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 2706000.00
XZO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 2706000.00
XZO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 901000.00
XZO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 127000.00
XZO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 901000.00
XZO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 127000.00
XZO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 90775789.00
XZO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.23
XZO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 21151000.00
XZO balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 13313000.00
XZO balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 1441000.00
XZO income_statement (quarterly, 2025-09-30) — EBIT: 28354000.00
XZO income_statement (quarterly, 2025-09-30) — EBITDA: 29255000.00
XZO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -115000.00
XZO cash_flow (quarterly, 2025-09-30) — End Cash Position: 140919000.00
XZO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 30302000.00
XZO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1102000.00
XZO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 18023000.00
XZO income_statement (quarterly, 2025-09-30) — Gross Profit: 33773000.00
XZO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 1432000.00
XZO income_statement (quarterly, 2025-09-30) — Interest Expense: 0.00
XZO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 0.00
XZO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 78432000.00
XZO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1189000.00
XZO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
XZO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5164000.00
XZO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5164000.00
XZO cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 93000.00
XZO income_statement (quarterly, 2025-09-30) — Net Income: 21151000.00
XZO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 21151000.00
XZO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 21151000.00
XZO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
XZO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 21151000.00
XZO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 21151000.00
XZO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 21151000.00
XZO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 21151000.00
XZO income_statement (quarterly, 2025-09-30) — Net Interest Income: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
XZO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 0.00
XZO balance_sheet (quarterly, 2025-09-30) — Net PPE: 18023000.00
XZO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1189000.00
XZO cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
XZO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 78432000.00
XZO balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 1298000.00
XZO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 1311000.00
XZO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 4023000.00
XZO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 4023000.00
XZO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 13000.00
XZO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 0.00
XZO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 28153000.00
XZO income_statement (quarterly, 2025-09-30) — Normalized Income: 20328908.00
XZO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 31491000.00
XZO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 93000.00
XZO income_statement (quarterly, 2025-09-30) — Operating Income: 27252000.00
XZO income_statement (quarterly, 2025-09-30) — Operating Revenue: 52909000.00
XZO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 90775789.00
XZO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1911000.00
XZO income_statement (quarterly, 2025-09-30) — Other Income Expense: 1102000.00
XZO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 274000.00
XZO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 709000.00
XZO balance_sheet (quarterly, 2025-09-30) — Other Properties: 18023000.00
XZO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 5379000.00
XZO balance_sheet (quarterly, 2025-09-30) — Payables: 18473000.00
XZO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 18473000.00
XZO cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: 0.00
XZO cash_flow (quarterly, 2025-09-30) — Preferred Stock Payments: 0.00
XZO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 1124000.00
XZO income_statement (quarterly, 2025-09-30) — Pretax Income: 28354000.00
XZO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1189000.00
XZO balance_sheet (quarterly, 2025-09-30) — Receivables: 13313000.00
XZO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 20619000.00
XZO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 901000.00
XZO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
XZO income_statement (quarterly, 2025-09-30) — Research And Development: 2494000.00
XZO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 3434000.00
XZO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3900000.00
XZO balance_sheet (quarterly, 2025-09-30) — Share Issued: 90775789.00
XZO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 731000.00
XZO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 78432000.00
XZO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 78432000.00
XZO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 279908.00
XZO income_statement (quarterly, 2025-09-30) — Tax Provision: 7203000.00
XZO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
XZO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Assets: 182254000.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 78432000.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Debt: 7515000.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 78432000.00
XZO income_statement (quarterly, 2025-09-30) — Total Expenses: 27914000.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 103822000.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 19608000.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 9896000.00
XZO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 27252000.00
XZO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1432000.00
XZO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1102000.00
XZO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1102000.00
XZO balance_sheet (quarterly, 2025-09-30) — Working Capital: 68720000.00
XZO income_statement (annual, 2025-12-31) — +Operating Expense: 25033000.00
XZO income_statement (quarterly, 2025-12-31) — +Operating Expense: 8060000.00
XZO income_statement (annual, 2025-12-31) — +Total Revenue: 216980000.00
XZO income_statement (quarterly, 2025-12-31) — +Total Revenue: 53316000.00
XZO balance_sheet (annual, 2025-12-31) — Accounts Payable: 7555000.00
XZO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 7555000.00
XZO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 2906000.00
XZO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 2906000.00
XZO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -13947000.00
XZO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -13947000.00
XZO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 228647000.00
XZO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 228647000.00
XZO income_statement (annual, 2025-12-31) — Basic Average Shares: 80171000.00
XZO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 84443000.00
XZO income_statement (annual, 2025-12-31) — Basic EPS: 0.99
XZO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.25
XZO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 54502000.00
XZO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 140919000.00
XZO cash_flow (annual, 2025-12-31) — Capital Expenditure: -2844000.00
XZO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -403000.00
XZO cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -2844000.00
XZO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 7245000.00
XZO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 7245000.00
XZO balance_sheet (annual, 2025-12-31) — Capital Stock: 91000.00
XZO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 91000.00
XZO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 305372000.00
XZO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 305372000.00
XZO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 305372000.00
XZO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 305372000.00
XZO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
XZO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
XZO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 153646000.00
XZO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 153646000.00
XZO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2844000.00
XZO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -403000.00
XZO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 100298000.00